Rate the Article: Performance Evaluation and Validation of Neodocs Hb Testing Point-Of-Care Device with Standard Laboratory Analyzer, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 3 | Views: 34 | Weekly Hits: ⮙2 | Monthly Hits: ⮙2

Research Paper | Hematology | India | Volume 14 Issue 5, May 2025 | Rating: 5.6 / 10


Performance Evaluation and Validation of Neodocs Hb Testing Point-Of-Care Device with Standard Laboratory Analyzer

Nikunj Malpani, Anurag Meena, Pratik Lodha, Shubham Munde


Abstract: Accurate Hb measurement is crucial for diagnosing and managing anemia. In India, anemia represents a significant public health crisis, affecting over 40% of the population and necessitating comprehensive interventions to address its widespread impact. In April 2018, the Indian Ministry of Health and Family Welfare launched the Anemia Mukt Bharat (AMB) strategy as a comprehensive national initiative to address and significantly reduce the substantial and pervasive public health issue of anemia within the country. Point-of-care testing (POCT) of anemia using digital hemoglobinometers and treatment is one of the primary interventions under AMB. To improve clinical decision-making and enable large-scale screening initiatives, our organization designed an innovative point-of-care Hb testing device that provides quick, accurate results. The analytical performance was assessed through a validation study performed at the Dr. Jariwala Laboratory, a NABL-accredited facility, ensuring the reliability and accuracy of the results. A total 3 batches with 30 samples provided capillary blood samples which underwent simultaneous analysis using the Neodocs (ND)- Hb device and a standard laboratory haematology analyzer (Mindray BC-780 Haematology System) to ensure accurate and comparable results. The device exhibited high precision and minimal variability across different hemoglobin ranges, demonstrating strength in detecting moderate-to-severe anemia. No significant operational errors or user-related issues were reported during the study, highlighting the device's usability in point-of-care settings. Further, the results were reproducible with maximum standard deviation 0.57, suitable for use on regular patient's sample.


Keywords: Anaemia, Point of care device, Neodocs, Traditional analyzer, Validation


Edition: Volume 14 Issue 5, May 2025,


Pages: 127 - 130



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top